Oxford Immunotec

The Winners And Losers Of JP Morgan Monday
Forbes
Mon, 01/8/18 - 10:23 pm
JPMHC 2018
Cellular Biomedicine
Alder Biopharmaceuticals
Nevro
Insulet
PTC Therapeutics
Axovant Sciences
Momenta
Natus Medical
Oxford Immunotec
EXACT Sciences
Oxford Immunotec gets $26 million in Series D
Tue, 05/4/10 - 05:36 pm
Oxford Immunotec
Series D
financing